Publication of inside information pursuant to Article 17 of Regulation (EU) No. 596/2014 (MAR)
Sales Euro 203.1 million (2022: Euro 272.2 million, -25 %) Incoming orders Euro 166.9 million (2022: Euro 248.4 m…
Sales Euro 203.1 million (2022: Euro 272.2 million, -25 %) Incoming orders Euro 166.9 million (2022: Euro 248.4 m…
Ad hoc announcement pursuant to Art. 53 LR Gurit (SIX Swiss Exchange: GURN) today reports net sales of CHF 459.9 millio…
Full-year revenue increased to CHF 2.4 billion and showed 9.8% organic revenue growth Fourth-quarter revenue amounte…
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, A…
2023 guidance met in full Strongest revenues in company’s history: revenues up 10.9% at approx. € 7.9 billion thanks to…
Organic revenue growth in 2023: +10.4% Organic adjusted EBITDA growth in 2023: +17.5% Favorable product mix boosts p…
Cloud Subscription Annual Recurring Revenue (ARR) in the fourth quarter and full-year 2023 increased 37% year-over-year…
Full-Year Highlights Sales $32.9 billion, down 2%, underlying sales up 5% Operating profit $8.0 billion; adjusted oper…
Unaudited results: Sales increase by 11% to EUR 133.8 million (Oct – Dec 2022: EUR 120.4 million); share of recurring…
Today, MedMira Inc. (MedMira) (TSXV: MIR) is pleased to provide an update on the ongoing review process by Health Canada…